XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.24.3

Detail of Certain Accounts | 9 Months Ended
--- | ---
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Detail of Certain Accounts | 15. DETAIL OF CERTAIN ACCOUNTS: Cash and Cash Equivalents As of September 30, 2024 and December 31, 2023, cash equivalents were $540.4 million and $610.8 million and consisted primarily of money market investments, money market mutual funds and short-term deposits. Cash and cash equivalents held by joint ventures, which are either consolidated or proportionately consolidated, are available to support joint venture operations, but Quanta cannot utilize those assets to support its other operations. Quanta generally has no right to cash and cash equivalents held by a joint venture other than participating in distributions, to the extent made, and in the event of dissolution. Cash and cash equivalents held by Quanta’s wholly-owned captive insurance company are generally not available for use in support of its other operations. Amounts related to cash and cash equivalents held by consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
|  | September 30, 2024 |  | December 31, 2023
Cash and cash equivalents held by domestic joint ventures |  | $ | 67,784 |  |  | $ | 41,427 |
Cash and cash equivalents held by foreign joint ventures |  | 10,687 |  |  | 10,968 |
Total cash and cash equivalents held by joint ventures |  | 78,471 |  |  | 52,395 |
Cash and cash equivalents held by captive insurance company |  | 19,319 |  |  | 19,088 |
Cash and cash equivalents not held by joint ventures or captive insurance company |  | 666,277 |  |  | 1,218,765 |
Total cash and cash equivalents |  | $ | 764,067 |  |  | $ | 1,290,248 |
Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following (in thousands):
|  | September 30, 2024 |  | December 31, 2023
Accounts payable, trade |  | $ | 2,317,040 |  |  | $ | 2,027,588 |
Accrued compensation and related expenses |  | 725,114 |  |  | 526,221 |
Other accrued expenses |  | 956,873 |  |  | 507,433 |
Accounts payable and accrued expenses |  | $ | 3,999,027 |  |  | $ | 3,061,242 |
Other accrued expenses primarily include accrued insurance liabilities as well as income and franchise taxes payable as of December 31, 2023. The amount as of September 30, 2024 also includes the current portion of contingent consideration as further described in Note 5 and the $107 million liability related to the Peru project dispute as further described in Note 14. Property and Equipment Accumulated depreciation related to property and equipment was $1.93 billion and $1.82 billion as of September 30, 2024 and December 31, 2023. In addition, Quanta held property and equipment, net of $196.3 million and $245.7 million in foreign countries, primarily Canada, as of September 30, 2024 and December 31, 2023. Other Intangible Assets Accumulated amortization related to other intangible assets was $1.57 billion and $1.31 billion as of September 30, 2024 and December 31, 2023.

X
- Definition Detail of certain balance sheet accounts. + References No definition available. + Details
Name: | pwr_DetailOfCertainBalanceSheetAccountsTextBlock
Namespace Prefix: | pwr_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration